See our latest thought leadership
Welcome to our resource hub dedicated to providing the latest insights on Precision Medicine, a rapidly evolving market. Here, you’ll find information on groundbreaking technologies such as liquid biopsy, gene therapy, and spatial omic imaging that are set to change treatment paradigms and improve clinical outcomes for patients1. Dive into our thinking and explore a range of topics that will equip you with the critical insights needed to inform key strategic decisions in the realm of Precision Medicine.
A new era of precision medicine
A new era of precision medicine: The unprecedented impact of generative AI across the precision medicine landscape
Download PDF2024 Healthcare and Life Sciences Investment Outlook
We analyze how eight subsectors fared and how deal activity and market drivers could shape the 2024 investment landscape.
The future of life sciences is connected, AI-driven, and patient-centric
The future of life sciences will likely be shaped by tech-enabled connectivity, strategic uses of AI, and patient-centric supply chains.
The Dawn of Precision Medicine in Neurodegenerative Diseases
We are on the precipice of Precision Medicine in neurodegenerative diseases (NDDs)
Spatial omics – microenvironments in full resolution
KPMG perspective on this innovative technology
Transfer Pricing Considerations in the Age of Precision Medicine
Disruption caused by chimeric antigen receptor T-cell (CAR T) therapy, a type of cell and gene therapy, to exploring standard business models in the life sciences industry.
Liquid Biopsy – What’s real and what’s hype?
KPMG perspective on this innovative technology
“One-and-done” gene therapies
A near-term niche?
Industry insights and trends, one click away.